Clinical trial

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly…

NCT00095771 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00095771
Title Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas
Official title A Phase I Trial of Arsenic Trioxide in the Treatment of Infiltrating Gliomas of Childhood
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Brain and Central Nervous System Tumors
Intervention type Drug, Radiation
Interventions arsenic trioxide, radiation therapy
Enrollment 36
Start date Nov 1, 2004
Primary completion Jan 1, 2011
Completion Jan 1, 2011
First posted Nov 9, 2004
Last update posted Apr 22, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies